BIT

BIOTRON FPO [BIT]
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225 for the treatment of SARS-CoV-2, HIV-1, hepatitis C virus, hepatitis B virus (HBV), influenza, and dengue virus infections. The company was incorporated in 1999 and is based in Sydney, Australia.
Healthcare · ASX Small Cap
$0.0020 -20.0%

Updated 3 Sep 2026 · Signals refresh every scan

Appeared in 2 consecutive scansFirst seen: 2026-03-05
Get alerts when BIT triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track BIT — Free

Active Signals

Bullish Signals

  • Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
  • Volatility is expanding fast — choppy price action, so buckle up
  • Low cash runway (3 quarters) - dilution risk
  • Near 52-week low (14% of range)
  • Micro-cap ($5-20M) - high risk
  • Sentiment is mixed — no strong consensus either way
  • This one has been in freefall — down 50% over the past year
  • The bigger volume days are the up days — volume-weighted momentum is positive (3.43%/day)
  • Pre-revenue company — Altman Z-Score not applicable
  • Penny stock risk ($0.002)
  • RBA hiking (-3pts)

Risk Signals

  • Below the 200-day average — the long-term trend is still working against it
  • Piotroski F-Score weak (3/9, low-confidence approx)
  • Not enough chatter to gauge sentiment — defaulting to neutral
Ask Scout AI about BIT
"What's driving BIT today?" "How does BIT compare to peers?" "Key risks for BIT?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

LOW Investor Presentation
NONE Appendix 4G
NONE Corporate Governance Statement
NONE Full Year Statutory Accounts and Appendix 4E

Recent ASX Announcements

2026-09-03 Investor Presentation
2026-08-27 Appendix 4G
2026-08-27 Corporate Governance Statement
2026-08-27 Full Year Statutory Accounts and Appendix 4E PRICE SENSITIVE
2026-08-18 Change in substantial holding

Key Metrics

$5.6M
Market Cap
6.2M
Avg Volume
0.5x
Vol Ratio
$0.00 — $0.01
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-122.6%
ROE
N/A
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 60%
LLeader vs LaggardlaggardRS: 0
IInstitutional Sponsorshipinsufficient_dataInst: 0%
MMarket DirectionneutralNeutral

Sector: Healthcare

113 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
REG -27.0%CAN +25.0%MEM +20.0%CMP -14.6%COV +14.3%
Compare:BIT vs REGBIT vs CANBIT vs MEM
Scout Pro — Deeper Analysis for BIT
Try Pro free for 30 days
Share this analysis

Track BIT and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required